PO.TB10.19 · 肿瘤生物学
解离、空间和功能性单细胞分析揭示HPV阴性HNSCC中肿瘤反应性T细胞的抗原驱动性耗竭和趋化失败
Dissociative, spatial, and functional single-cell profiling reveals antigen-driven exhaustion and chemotactic failure of tumor-reactive T cells in HPV-negative HNSCC
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:HPV阴性头颈部鳞状细胞癌(HNSCC)仍具有高度致死性,即使近期的KEYNOTE-689试验也显示对PD-1阻断的应答有限。为阐明免疫耐药机制,我们对HPV阴性HNSCC进行了多组学单细胞分析,以界定肿瘤反应性T细胞的状态、克隆型和空间生态位。
方法:两例未经治疗的HPV阴性HNSCC患者接受了手术肿瘤取样。活检标本分别用于解离性单细胞RNA和TCR测序、在Bruker CosMx平台上进行带TCR附加的单细胞空间全转录组成像,以及在Bruker Beacon系统上对自体肿瘤细胞和肿瘤浸润淋巴细胞(TIL)进行功能性共培养,并通过机器人回收反应性克隆随后进行单细胞TCR测序。
结果:解离和空间数据集质量良好,解离聚类指导了空间注释。出现了两个肿瘤反应性TIL群体:一个以终末耗竭和克隆超扩增为特征的转录反应性群体,以及一个在Beacon平台上通过肿瘤杀伤和IFNgamma分泌鉴定的功能反应性群体。二者均未出现在邻近正常黏膜中。空间投射显示功能反应性克隆型沿拟时序连续体推进,从轻度耗竭的基质状态向恶性上皮岛内深度耗竭但仍具增殖能力的状态发展。转录反应性TIL共享这种耗竭-增殖表型,并主要定位于肿瘤岛内。相反,Treg和免疫抑制性巨噬细胞局限于基质区域,与肿瘤反应性T细胞的空间重叠极少。恶性上皮强烈富集CXCL14(较基质高出十倍以上),但肿瘤反应性TIL仍稀少,肿瘤与反应性T细胞比例大于20比1。
结论:这是首个整合解离、空间和功能性单细胞分析来界定实体瘤中肿瘤反应性TIL生物学特征的研究。我们发现肿瘤反应性T细胞能够浸润恶性上皮岛,且其最深浸润对应最耗竭的状态,表明慢性抗原刺激是功能障碍的主要驱动因素。抑制性细胞局限于基质生态位提示其影响是通过维持限制性屏障基质而非通过邻近抑制发挥的。这些发现共同强调了肿瘤反应性T细胞趋化募集不足是有效抗肿瘤免疫的核心障碍。CXCL14在上皮的强烈富集使其成为增强肿瘤定向T细胞迁移的有前景候选分子。
查看英文原文 English abstract
Introduction: HPV-negative head and neck squamous cell carcinoma (HNSCC) remains highly lethal, and even the recent KEYNOTE-689 trial showed limited response to PD-1 blockade. To clarify mechanisms of immunoresistance, we performed multi-omic single-cell profiling of HPV-negative HNSCC to define the states, clonotypes, and spatial niches of tumor-reactive T cells.
Methods: Two patients with untreated HPV-negative HNSCC underwent surgical tumor sampling. Biopsies were allocated for dissociative single-cell RNA and TCR sequencing, for single-cell spatial whole transcriptome imaging with TCR add-in on the Bruker CosMx platform, and for functional co-culture of autologous tumor cells and tumor-infiltrating lymphocytes (TILs) on the Bruker Beacon system with robotic retrieval of reactive clones followed by single-cell TCR sequencing.
Results: Dissociative and spatial datasets were high quality, and dissociative clustering guided spatial annotation. Two tumor-reactive TIL populations emerged: a transcriptionally reactive population marked by terminal exhaustion and clonal hyper-expansion, and a functionally reactive population identified on the Beacon platform through tumor-killing and IFNgamma secretion. Neither appeared in adjacent normal mucosa. Spatial projection showed functionally reactive clonotypes progressing along a pseudotime continuum from minimally exhausted stromal states toward a deeply exhausted yet proliferative state within malignant epithelial islands. Transcriptionally reactive TILs shared this exhausted-proliferative phenotype and primarily localized within tumor islands. Conversely, Tregs and immunosuppressive macrophages were confined to stromal regions and showed minimal spatial overlap with tumor-reactive T cells. Malignant epithelium strongly enriched CXCL14 (> ten-fold over stroma), yet tumor-reactive TILs remained rare, with a tumor-to-reactive T cell ratio greater than 20 to 1.
Conclusions: This is the first study to integrate dissociative, spatial, and functional single-cell analytics to define tumor-reactive TIL biology in solid tumors. We find that tumor-reactive T cells can infiltrate malignant epithelial islands, and that their deepest infiltration corresponds to the most exhausted states, indicating that chronic antigen stimulation is the primary driver of dysfunction. The confinement of suppressive cells to stromal niches suggests that their influence is exerted through maintenance of a restrictive barrier stroma rather than through proximity-based inhibition. Together, these findings highlight insufficient chemotactic recruitment of tumor-reactive T cells as a central barrier to effective antitumor immunity. The strong epithelial enrichment of CXCL14 positions it as a promising candidate for enhancing tumor-directed T cell migration.
利益披露 Disclosure
J. Zenga, None..
F. Sun, None..
A. Memon, None..
T. Kearl, None..
E. Norenberg, None..
E. Hobbs, None..
R. Liu, None..
D. McGuire, None.